A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

MIT springs drug-delivery spinout MIT has launched an as-yet unnamed spinout to develop a smart drug-delivery pill to help plan more effective treatment regimens for patients. Metcalf leaves MIT for TSEF Impact investment unit TSEF has appointed Lara Metcalf to direct the investment strategy of its third fund focused on financial, health and human services technologies. Istesso stamps $7.8m extension The funding takes Istesso’s latest round to $13m as the company continues clinical trials on an immunometabolic drug licensed from an Aberdeen spinout in 2007. Marinomed hits Vienna Stock Exchange VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m. Sustainable Bioproducts sucks in $33m Danone Manifesto Ventures and ADM Ventures both took part in a series A round for the Montana State University-backed Nasa spinout, which is developing edible proteins. HTGF adds flavour to 4Gene’s seed round 4Gene is advancing TUM research into exploiting plant-derived glucosides as flexible triggers for releasing flavouring and aromas. Andrén draws curtain at Cicada Innovations Multi-university-backed incubator Cicada Innovations has lost its chief executive and managing director Petra Andrén, who has decided to spend more time with her family. Bolt hits series B with $54m Nan Fung Life Sciences and Novo have taken part in a series B round for Stanford’s immuno-oncology drug developer Bolt Biotherapeutics. C-Capture catches $4.6m IP Group returned to join corporates BP and Drax for the Leeds CO2 capture spinout’s latest round, taking its total investment in the company to $2.2m since 2009. Berkeley encrypts Blockchain Xcelerator UC Berkeley will offer participants up to $200,000 from its X-Fund as it looks to build a blockchain ecosystem connecting resources from university departments, Silicon Valley and further afield. Ligand Pharmaceuticals administers $3m to Dianomi Dianomi Therapeutics will work with Ligand on a medication delivery platform based on research from University of Wisconsin-Madison initially targeting pain disorders and osteoarthritis. Spin Memory banks Abies for series B NYU and Allied Minds-founded Ram technology developer Spin Memory has unveiled deep tech-focused VC firm Abies Ventures as an investor in a $52m series B first announced late last year.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?